{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:11:20Z","timestamp":1793203880022,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006470","name":"Aristotle University of Thessaloniki","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006470","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dimethyl fumarate (DMF) is an electrophilic compound used clinically for multiple sclerosis and psoriasis. We elaborate here that the pharmacological effects of DMF extend beyond the well-known activation of the NRF2 antioxidative pathway. Indeed, DMF directly modifies reactive cysteine residues on multiple proteins in immune and neural cells, leading to diverse anti-inflammatory, immunomodulatory, and neuroprotective actions. Recent studies revealed that DMF may affect proteins involved in inflammasome activation, glycolysis, and cell signaling pathways, including JAK-STAT and NF-kB. These effects may expand the potential clinical applications of DMF in diverse pathologies, including neurodegenerative, cardiovascular, and pulmonary diseases. We summarize current findings on chemical reactivity, target proteins, and emerging clinical applications of DMF, highlighting new opportunities for DMF repurposing.<\/jats:p>","DOI":"10.1007\/s11033-026-11478-7","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T11:55:25Z","timestamp":1770033325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Dimethyl fumarate as a versatile therapeutic agent: molecular mechanisms and potential clinical applications"],"prefix":"10.1007","volume":"53","author":[{"given":"Eleni","family":"Zingkou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Medoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Davinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Saso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Sotiropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Pampalakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"11478_CR1","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1046\/j.1365-2133.1999.03034.x","volume":"141","author":"U Mrowietz","year":"1999","unstructured":"Mrowietz U, Christophers E, Altmeyer P (1999) Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. The German Fumaric Acid Ester Consensus Conference. Br J Dermatol 141:424\u2013429","journal-title":"Br J Dermatol"},{"key":"11478_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jdv.15218","volume":"S3","author":"U Mrowietz","year":"2018","unstructured":"Mrowietz U, Barker J, Boehncke W-H, Iversen L, Kirby B, Naldi L, Reich K, Tanew A, van de Kerkhof PCM, Warren RB (2018) Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a Europena expert consensus. J Eur Acad Dermatol Venereol S3:3\u201314","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"11478_CR3","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.3390\/antiox11101924","volume":"11","author":"F Manai","year":"2022","unstructured":"Manai F, Amadio M (2022) Dimethyl fumarate triggers the antioxidant defense system in human retinal endothelial cells through Nrf2 activation. Antioxidants 11:1924","journal-title":"Antioxidants"},{"key":"11478_CR4","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1073\/pnas.1603907113","volume":"113","author":"U Schulze-Topphoff","year":"2016","unstructured":"Schulze-Topphoff U, Varrin-Doyer M, Pekarek K, Spencer CM, Shetty A, Sagan SA, Cree BAC, Sobel RA, Wipke BT, Steinman L, Scannevin RH, Zamvil SS (2016) Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2. Proc Natl Acad Sci U S A 113:4777\u20134782","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11478_CR5","doi-asserted-by":"publisher","DOI":"10.1042\/AN20100033","volume":"3","author":"SX Lin","year":"2011","unstructured":"Lin SX, Lisi L, Russo CD, Polak PE, Sharp A, Weinberg G, Kalinin S, Feinstein DL (2011) The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and heam oxygenase-1. ASN Neuro 3:e00055","journal-title":"ASN Neuro"},{"key":"11478_CR6","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S1474-4422(19)30391-6","volume":"19","author":"T Derfuss","year":"2020","unstructured":"Derfuss T, Mehling M, Papadopoulou A, Bar-Or A, Cohen JA, Kappos L (2020) Advances in oral immunomodulating therapies in relapsing multiple sclerosis. Lancet Neurol 19:336\u2013347","journal-title":"Lancet Neurol"},{"key":"11478_CR7","first-page":"53","volume":"15","author":"U Mrowietz","year":"2022","unstructured":"Mrowietz U, Kircik L, Reich K, Munjal S, Shenoy S, Lebwohl M (2022) Tepilamide fumarate (PPC-06) extended release tablets in patients with moderate-to-severe plaque psoriasis: safety and efficacy results from the randomized, double-blind, placebo-controlled AFFIRM study. J Clin Aesthet Dermatol 15:53\u201358","journal-title":"J Clin Aesthet Dermatol"},{"key":"11478_CR8","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1074\/mcp.RA118.000922","volume":"18","author":"GG Piroli","year":"2019","unstructured":"Piroli GG, Manueal AM, Patel T, Walla MD, Shi L, Lanci SA, Wang J, Galloway A, Ortinski PI, Smith DS, Frizzell N (2019) Identification of novel protein targets of dimethyl fumarate modification in neurons and astrocytes reveals actions independent of Nrf2 stabilization. Mol Cell Proteomics 18:504\u2013519","journal-title":"Mol Cell Proteomics"},{"key":"11478_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaf7694","volume":"9","author":"MM Blewett","year":"2016","unstructured":"Blewett MM, Xie J, Zaro BW, Backus KM, Altman A, Teijaro JR, Cravatt BF (2016) Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells. Sci Signal 9:rs10","journal-title":"Sci Signal"},{"key":"11478_CR10","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1021\/acs.jproteome.3c00179","volume":"22","author":"W Xiao","year":"2023","unstructured":"Xiao W, Chen Y, Zhang J, Guo Z, Hu Y, Yang F, Wang C (2023) A simplified and ultrafast pipeline for site-specific quantitative chemical proteomics. J Proteome Res 22:3360\u20133367","journal-title":"J Proteome Res"},{"key":"11478_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1021\/acschembio.4c00617","volume":"20","author":"L Zhang","year":"2025","unstructured":"Zhang L, Martin JG, Gao B, Zeng W, Couvertier S, Johnson DS (2025) Chemoproteomic profiling of clickable fumarate probes for target identification and mechanism of action studies. ACS Chem Biol 20:340\u2013356","journal-title":"ACS Chem Biol"},{"key":"11478_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-1-61779-885-6_9","volume":"893","author":"L Dayon","year":"2012","unstructured":"Dayon L, Sanchez J-C (2012) Relative protein quantification by MS\/MS using the tandem mass tag technology. Methods Mol Biol 893:115\u2013127","journal-title":"Methods Mol Biol"},{"key":"11478_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120254","volume":"10","author":"MS Brennan","year":"2015","unstructured":"Brennan MS, Matos MF, Li B, Hronowski X, Gao B, Juhasz P, Rhodes KJ, Scannevin RH (2015) Dimethyl fumarate and monomethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro. PLoS One 10:e0120254","journal-title":"PLoS One"},{"key":"11478_CR14","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1128\/MCB.01704-07","volume":"28","author":"T Yamamoto","year":"2008","unstructured":"Yamamoto T, Suzuki T, Kobayashi A, Wakabayashi J, Maher J, Motohashi H, Yamamoto M (2008) Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol Cell Biol 28:2758\u20132770","journal-title":"Mol Cell Biol"},{"key":"11478_CR15","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1126\/science.abb9818","volume":"369","author":"F Humphries","year":"2020","unstructured":"Humphries F, Shmuel-Galia L, Ketelut-Carneiro N, Li S, Wang B, Nemmara VV, Wilson R, Jiang Z, Khalighinejad F, Muneeruddin K, Shaffer SA, Dutta R, Ionete C, Pesiridis S, Yang S, Thompson PR, Fitzgerald KA (2020) Succination inactivates gasdermin D and blocks pyroptosis. Science 369:1633\u20131637","journal-title":"Science"},{"key":"11478_CR16","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1084\/jem.20190377","volume":"216","author":"S Li","year":"2019","unstructured":"Li S, Wu Y, Yang D, Wu C, Ma C, Liu X, Moynagh PN, Wang B, Hu G, Yang S (2019) Gasdermin D in peripheral myeloid cells drives neuroinflammation in experimental autoimmune encephalomyelitis. J Exp Med 216:2562\u20132581","journal-title":"J Exp Med"},{"key":"11478_CR17","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1074\/mcp.RA118.000922","volume":"18","author":"GG Piroli","year":"2019","unstructured":"Piroli GG, Manuel AM, Patel T, Walla MD, Shi L, Lanci SA, Wang J, Galloway A, Ortinski PI, Smith DS, Frizzell N (2019) Identification of novel protein targets of dimethyl fumarate modification in neurons and astrocytes reveals actions independent of Nrf2 stabilization. Mol Cell Proteomics 18:504\u2013519","journal-title":"Mol Cell Proteomics"},{"key":"11478_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1042\/BJ20131581","volume":"462","author":"GG Piroli","year":"2014","unstructured":"Piroli GG, Manuel AM, Walla MD, Jepson MJ, Brock JWC, Rajesh MP, Tanis RM, Cotham WE, Frizzell N (2014) Identification of protein succination as a novel modification of tubulin. Biochem J 462:231\u2013245","journal-title":"Biochem J"},{"key":"11478_CR19","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1182\/blood.2020009404","volume":"138","author":"A Schmitt","year":"2021","unstructured":"Schmitt A, Xu W, Bucher P, Grimm M, Konantz M, Horn H, Zapukhlyak M, Berning P, Br\u00e4ndle M, Jarboui M-A, Sch\u00f6nfeld C, Boldt K, Rosenwald A, Ott G, Grau M, Klener P, Vockova P, Lengerke C, Lenz G, Schulze-Osthoff K, Hailfinger S (2021) Dimethyl fumarate induces ferroptosis and impairs NF-\u03baB\/STAT3 signaling in DLBCL. Blood 138:871\u2013884","journal-title":"Blood"},{"key":"11478_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2025.2504633","volume":"47","author":"X An","year":"2025","unstructured":"An X, Yin M, Shen Y, Guo X, Xu Y, Cheng D, Gui D (2025) Dimethyl fumarate ameliorated pyroptosis in contrast-induced acute renal injury by regulating endoplasmic reticulum stress and JAK2-STAT3 pathway. Ren Fail 47:2504633","journal-title":"Ren Fail"},{"key":"11478_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109544","volume":"27","author":"H Hu","year":"2024","unstructured":"Hu H, Cai Y, Shi Y, Zhang S (2024) Dimethyl fumarate covalently modified Cys673 of NLRP3 to exert anti-inflammatory effects. iScience 27:109544","journal-title":"iScience"},{"key":"11478_CR22","doi-asserted-by":"crossref","unstructured":"Zhang Y, Lindner H, So B, Chen Z, Li H, Xu J, Wang J, Xu J, Petre AM, Distefano MD, N\u00fa\u00f1ez G, Lin H (2025) Chemoproteomics of dimethyl fumarate reveals NEK7 Cys298 as a therapeutic target in NLRP3 inflammasome activation. (PREPRINT)","DOI":"10.2139\/ssrn.5274634"},{"key":"11478_CR23","doi-asserted-by":"crossref","unstructured":"Shi A, Shu Y, Hu K, Sudesh S, Tu (2025) NLRP3-inflammasome related genes as emerging biomarkers and therapeutic targets in psoriasis. Inflammation (in press)","DOI":"10.1007\/s10753-025-02271-y"},{"key":"11478_CR24","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1126\/science.aan4665","volume":"360","author":"MD Kornberg","year":"2018","unstructured":"Kornberg MD, Bhargava P, Kim PM, Putluri V, Snowman AM, Putluri N, Calabresi PA, Snyder SH (2018) Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science 360:449\u2013453","journal-title":"Science"},{"key":"11478_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.617714","volume":"12","author":"K Chen","year":"2021","unstructured":"Chen K, Wu S, Ye S, Huang H, Zhou Y, Zhou H, Wu S, Mao Y, Shangguan F, Lan L, Chen B (2021) Dimethyl fumarate induces metabolic crisie to suppress pancreatic carcinoma. Front Pharmacol 12:617714","journal-title":"Front Pharmacol"},{"key":"11478_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-05443-4","volume":"6","author":"MC Oca\u00f1a","year":"2023","unstructured":"Oca\u00f1a MC, Bernal M, Yang C, Caro C, Dom\u00ednguez A, Vu HS, C\u00e1rdenas C, Garc\u00eda-Mart\u00edn ML, DeBerardinis RJ, Quesada AR, Mart\u00ednez-Poveda B, Medina MA (2023) New insights in the targets of action of dimethyl fumarate in endothelial cells: effects on energetic metabolism and serine synthesis in vitro and in vivo. Commun Biol 6:1084","journal-title":"Commun Biol"},{"key":"11478_CR27","doi-asserted-by":"crossref","unstructured":"Alam Q, Krishnamurthy S, Tomar M (2023) Dimethyl fumarate as a covalent inhibitor of cathepsin C: a novel mechanism of action explored in in-vitro and in-vivo. Research Square (Preprint)","DOI":"10.21203\/rs.3.rs-2594608\/v1"},{"key":"11478_CR28","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1172\/JCI72151","volume":"124","author":"H Chen","year":"2014","unstructured":"Chen H, Assmann JC, Krenz A, Rahman M, Grimm M, Karsten CM, K\u00f6hl J, Offermanns S, Wettschureck N, Schwaninger M (2014) Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate\u2019s protective effect in EAE. J Clin Invest 124:2188\u20132192","journal-title":"J Clin Invest"},{"key":"11478_CR29","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.98970","volume":"14","author":"J Kosinska","year":"2025","unstructured":"Kosinska J, Assman JC, Inderhees J, M\u00fcller-Fielitz H, H\u00e4ndler K, Geisler S, K\u00fcnstner A, Busch H, Worthmann A, Heeren J, Sadik CD, Gunzer M, Pr\u00e9vot V, Nogueiras R, Hirose M, Spielmann M, Offermanns S, Wettschureck N, Schwaninger M (2025) Diet modulates the therapeutic effects of dimethyl fumarate mediated by the immunometabolic neutrophil receptor HCAR2. Elife 14:e98970","journal-title":"Elife"},{"key":"11478_CR30","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.4049\/jimmunol.1801627","volume":"202","author":"BW Zaro","year":"2019","unstructured":"Zaro BW, Vinogradova EV, Lazar DC, Blewett MM, Suciu RM, Takaya J, Studer S, de la Torre JC, Casanova J-L, Cravatt BF, Teijaro JR (2019) Dimethyl fumarate disrupts human innate immune signaling by targeting the IRAK4-MyD88 complex. J Immunol 202:2737\u20132746","journal-title":"J Immunol"},{"key":"11478_CR31","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/(SICI)1098-1004(1998)11:6<482::AID-HUMU14>3.0.CO;2-H","volume":"11","author":"FX Arrendondo-Vega","year":"1998","unstructured":"Arrendondo-Vega FX, Santisteban I, Notarangelo LD, El Dahr J, Buckley R, Roifman C, Conley ME, Hershfield MS (1998) Seven novel mutations in the adenosine deaminase (ADA) gene in patients with severe and delayed onset combined immunodeficiency: G74C, V129M, G140E, R149W, Q199P, 462delG, and E337del. Mutations in brief no. 142. Online. Hum Mutat 11:482","journal-title":"Hum Mutat"},{"key":"11478_CR32","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1177\/1352458517690617","volume":"23","author":"S Gopal","year":"2017","unstructured":"Gopal S, Mikulskis A, Gold R, Fox RJ, Dawson KT, Amaravadi L (2017) Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the phase 3 DEFINE and CONFIRM studies. Mult Scler 23:1875\u20131883","journal-title":"Mult Scler"},{"key":"11478_CR33","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.tibs.2024.05.003","volume":"49","author":"I Guberovic","year":"2024","unstructured":"Guberovic I, Frezza C (2024) Functional implications of fumarate-induced cysteine succination. Trends Biochem Sci 49:775\u2013790","journal-title":"Trends Biochem Sci"},{"key":"11478_CR34","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.cmet.2023.04.017","volume":"35","author":"J Cheng","year":"2023","unstructured":"Cheng J, Yan J, Liu Y, Shi J, Wang H, Zhou H, Zhou Y, Zhang T, Zhao L, Meng X, Gong H, Zhang X, Zhu H, Jiang P (2023) Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8+ T cells in the tumor microenvironment. Cell Metabol 35:961\u2013978","journal-title":"Cell Metabol"},{"key":"11478_CR35","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1074\/mcp.M115.051516","volume":"15","author":"GG Piroli","year":"2015","unstructured":"Piroli GG, Manuel AM, Clapper AC, Walla MD, Baatz JE, Palmiter RD, Quintana A, Frizzell N (2015) Succination is increased on select proteins in the brainstem of the NADH dehydrogenase (ubiquinone) Fe-S protein (Ndusf4) knockout mouse, a model of Leigh syndrome. Mol Cell Proteomics 15:445\u2013461","journal-title":"Mol Cell Proteomics"},{"key":"11478_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.brainres.2018.02.016","volume":"1686","author":"I Majkutewicz","year":"2018","unstructured":"Majkutewicz I, Kurowska E, Podlacha M, My\u015bli\u0144ska D, Grembecka B, Ruci\u0144ski J, Pierzynowska K, Wrona D (2018) Age-dependent effects of dimethyl fumarate on cognitive and neuropathological features in the streptozotocin-induced rat model of Alzheimer\u2019s disease. Brain Res 1686:19\u201333","journal-title":"Brain Res"},{"key":"11478_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/JIR.S342280","volume":"15","author":"D Wrona","year":"2022","unstructured":"Wrona D, Majkutewicz I, \u015awiatek G, Dunacka J, Grembecka B, Glac W (2022) Dimethyl fumarate as the peripheral blood inflammatory mediators inhibitor in prevention of streptozotocin-induced neuroinflammation in aged rats. J Inflamm Res 15:33\u201352","journal-title":"J Inflamm Res"},{"key":"11478_CR38","doi-asserted-by":"publisher","first-page":"15449","DOI":"10.3390\/ijms232415449","volume":"23","author":"E Kurowska-Ruci\u0144ska","year":"2022","unstructured":"Kurowska-Ruci\u0144ska E, Ruci\u0144ski J, My\u015bli\u0144ska D, Grembecka B, Wrona D, Majkutewicz I (2022) Dimethyl fumarate alleviates adult neurogenesis disruption in hippocampus and olfactory bulb and spatial cognitive deficits induced by intracerebroventricular streptozotocin injection in young and aged rats. Int J Mol Sci 23:15449","journal-title":"Int J Mol Sci"},{"key":"11478_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12974-024-03046-2","volume":"21","author":"T Wang","year":"2024","unstructured":"Wang T, Sobue A, Watanabe S, Komine O, Saido TC, Saito T, Yamanaka K (2024) Dimethyl fumarate improves cognitive impairment and neuroinflammation in mice with Alzheimer\u2019s disease. J Neuroinflammation 21:55","journal-title":"J Neuroinflammation"},{"key":"11478_CR40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neuroscience.2014.11.047","volume":"286","author":"X Jing","year":"2015","unstructured":"Jing X, Shi H, Zhang C, Ren M, Han M, Wei X, Zhang X, Lou H (2015) Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson\u2019s disease by enhancing Nrf2 activity. Neuroscience 286:131\u2013140","journal-title":"Neuroscience"},{"key":"11478_CR41","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1089\/ars.2016.6800","volume":"27","author":"M Campolo","year":"2017","unstructured":"Campolo M, Casili G, Biundo F, Crupi R, Cordaro M, Cuzzocrea S, Esposito E (2017) The neuroprotective effect of dimethyl fumarate in an MPTP-mouse model of Parkinson\u2019s disease: involvement of reactive oxygen species\/nuclear factor-\u03baB\/nuclear transcription factor related to NF-E2. Antioxid Redox Signal 27:453\u2013471","journal-title":"Antioxid Redox Signal"},{"key":"11478_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148462","volume":"1815","author":"M Khot","year":"2023","unstructured":"Khot M, Sood A, Tryphena KP, Piniata P, Srivastava S, Singh SB, Khatri DK (2023) Dimethyl fumarate ameliorates parkinsonian pathology by modulating autophagy and apoptosis via Nrf2-TIGAR-LAMP2\/cathepsin D axis. Brain Res 1815:148462","journal-title":"Brain Res"},{"key":"11478_CR43","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3233\/ADR-230128","volume":"8","author":"P Pinjala","year":"2024","unstructured":"Pinjala P, Tryphena KP, Kulkarni A, Goswami PG, Kharti DK (2024) Dimethyl fumarate exerts a neuroprotective effect by enhancing mitophagy via the NRF2\/BINP3\/PINK1 axis in the MPP+ iodide-induced Parkinson\u2019s disease mice model. J Alzheimers Dis Rep 8:329\u2013344","journal-title":"J Alzheimers Dis Rep"},{"key":"11478_CR44","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s11094-024-03132-y","volume":"58","author":"G Angelis","year":"2024","unstructured":"Angelis G, Tsingotjidou A, Iatridis N, Pampalakis G (2024) Dimethyl fumarate ameliorates the amyotrophic lateral sclerosis symptoms in Tg-SOD1G93A mice. Pharm Chem 58:180\u2013186","journal-title":"Pharm Chem"},{"key":"11478_CR45","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5343462","volume":"2018","author":"Y-J Lin","year":"2018","unstructured":"Lin Y-J, Lin I-C, Yu H-R, Sheen J-M, Huang L-T, Tain Y-L (2018) Early postweaning treatment with dimethyl fumarate prevents prenatal dexamethasone-and postnatal high-fat diet-induced programmed hypertension in male rat offspring. Oxid Med Cell Longev 2018:5343462","journal-title":"Oxid Med Cell Longev"},{"key":"11478_CR46","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10506","volume":"22","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Zhang F, Jiang H, Xu D, Deng D (2021) Fumaric and succinic acid treat gestational hypertension by downregulating the expression of KCNMB1 and TET1. Exp Ther Med 22:1072","journal-title":"Exp Ther Med"},{"key":"11478_CR47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12974-016-0733-1","volume":"13","author":"R Lin","year":"2016","unstructured":"Lin R, Cai J, Kostuk EW, Rosenwasser R, Iacovitti L (2016) Fumarate modulates the immune\/inflammatory response and rescues nerve cells and neurological function after stroke in rats. J Neuroinflammation 13:269","journal-title":"J Neuroinflammation"},{"key":"11478_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107844","volume":"98","author":"N Yan","year":"2021","unstructured":"Yan N, Xu Z, Qu C, Zhang J (2021) Dimethyl fumarate improves cognitive deficits in chronic cerebral hypoperfusion rats by alleviated inflammation, oxidative stress, and ferroptosis via NRF2\/ARE\/NF-\u03baB signal pathway. Int Immunopharmacol 98:107844","journal-title":"Int Immunopharmacol"},{"key":"11478_CR49","doi-asserted-by":"publisher","first-page":"15540","DOI":"10.3390\/ijms242115540","volume":"24","author":"MK Schuhmann","year":"2023","unstructured":"Schuhmann MK, Langhauser F, Zimmermann L, Bellut M, Kleinschnitz C, Fluri F (2023) Dimethyl fumarate attenuates lymphocyte infiltration and reduces infarct size in experimental stroke. Int J Mol Sci 24:15540","journal-title":"Int J Mol Sci"},{"key":"11478_CR50","first-page":"153","volume":"4","author":"OA Nour","year":"2017","unstructured":"Nour OA, Shehatou GSG, Rahim MA, El-Awady MS, Suddek GM (2017) Antioxidant and anti-inflammatory effects of dimethyl fumarate in hypercholesterolemic rabbits. Egypt J Basic Appl Sci 4:153\u2013159","journal-title":"Egypt J Basic Appl Sci"},{"key":"11478_CR51","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/jdv.16635","volume":"35","author":"G Holzer","year":"2021","unstructured":"Holzer G, Hoke M, Sabeti-Sandor S, Perkmann T, Rauscher A, Stassegger B, Radakovic S, Tanew A (2021) Disparate effects of adalimumab and fumaric acid esters on cardiovascular risk factors in psoriasis patients: results from a prospective, randomized, observer-blinded head-to-head trial. J Eur Acad Dermatol Venereol 35:441\u2013449","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"11478_CR52","volume":"5","author":"SB Kan","year":"2019","unstructured":"Kan SB, Staun-Ram E, Golan D, Miller A (2019) HDL-cholesterol elevation associated with fingolimod and dimethyl fumarate therapies in multiple sclerosis. Mult Scler J 5:2055217319882720","journal-title":"Mult Scler J"},{"key":"11478_CR53","first-page":"446","volume":"25","author":"K Zyla","year":"2019","unstructured":"Zyla K, Larabee CM, Georgescu C, Berkley C, Reyna T, Plafker SM (2019) Dimethyl fumarate mitigates optic neuritis. Mol Vis 25:446\u2013461","journal-title":"Mol Vis"},{"key":"11478_CR54","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/ijms22010297","volume":"22","author":"S Mori","year":"2020","unstructured":"Mori S, Kurimoto T, Maeda H, Nakamura M (2020) Dimethyl fumarate promotes the survival of retinal ganglion cells after optic nerve injury, possible through the Nrf2\/HO-1 pathway. Int J Mol Sci 22:297","journal-title":"Int J Mol Sci"},{"key":"11478_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.601628","volume":"11","author":"M Dietrich","year":"2021","unstructured":"Dietrich M, Hecker C, Nasiri M, Samsam S, Issberner A, Kohne Z, Hartung H-P, Albrecht P (2021) Neuroprotective properties of dimethyl fumarate measured by optical coherence tomography in non-inflammatory animal models. Front Neurol 11:601628","journal-title":"Front Neurol"},{"key":"11478_CR56","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/archopht.125.4.569","volume":"125","author":"C Heinz","year":"2007","unstructured":"Heinz C, Heiligenhaus A (2007) Improvement of noninfectious uveitis with fumaric acid esters: results of a pilot study. Arch Ophthalmol 125:569\u2013571","journal-title":"Arch Ophthalmol"},{"key":"11478_CR57","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s10792-018-0982-3","volume":"39","author":"L Kofler","year":"2019","unstructured":"Kofler L, Kathrein-Schneider S, Schweinzer K, Kofler H (2019) Fumaric acid: a possible new therapy for macular edema? Int Ophthalmol 39:1627\u20131631","journal-title":"Int Ophthalmol"},{"key":"11478_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ph16070974","volume":"16","author":"S Giunta","year":"2023","unstructured":"Giunta S, D\u2019Amico AG, Maugeri G, Bucolo C, Romano GL, Rossi S, Eandi CM, Pricoco E, D\u2019Agata V (2023) Drug-repurposing strategy for dimethyl fumarate. Pharmaceuticals 16:974","journal-title":"Pharmaceuticals"},{"key":"11478_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/srep41605","volume":"7","author":"AP Grzegorzewska","year":"2017","unstructured":"Grzegorzewska AP, Seta F, Han R, Czajka CA, Makino K, Stawski L, Isenberg JS, Browning JL, Trojanowska M (2017) Dimethyl fumarate ameliorates pulmonary arterial hypertension and lung fibrosis by targeting multiple pathways. Sci Rep 7:41605","journal-title":"Sci Rep"},{"key":"11478_CR60","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3390\/antiox11030492","volume":"11","author":"K Kato","year":"2022","unstructured":"Kato K, Papageorgiou I, Shin Y-J, Kleinhenz JM, Palumbo S, Hahn S, Irish JD, Rounseville SP, Knox KS, Hecker L (2022) Lung-targeted delivery of dimethyl fumarate promotes the reversal of age-dependent established lung fibrosis. Antioxidants 11:492","journal-title":"Antioxidants"},{"key":"11478_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01435-4","volume":"20","author":"J Liu","year":"2022","unstructured":"Liu J, Wu Z, Liu Y, Zhan Z, Yang L, Wang C, Jiang Q, Ran H, Li P, Wang Z (2022) ROS-responsive liposomes as an inhaled drug delivery nanoplatform for idiopathic pulmonary fibrosis treatment via Nrf2 signaling. J Nanobiotechnology 20:231","journal-title":"J Nanobiotechnology"},{"key":"11478_CR62","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1042\/CS20210792","volume":"136","author":"BF Pinto","year":"2022","unstructured":"Pinto BF, Ribeiro LNB, da Silva GBRF, Freitas CS, Kraemer L, Oliveira FMS, Cl\u00edmaco MC, Mour\u00e3o FAG, Santos GSPD, B\u00e9la SR, Gurgel ILDS, Leite FDL, de Oliveira AG, Vilela MRSDP, Oliveira-Lima OC, Soriani FM, Fujiwara RT, Birbrair A, Russo RC, Carvalho-Tavares J (2022) Inhalation of dimethyl fumarate-encapsulated solid lipid nanoparticles attenuate clinical signs of experimental autoimmune encephalomyelitis and pulmonary inflammatory dysfunction in mice. Clin Sci Lond 136:81\u2013101","journal-title":"Clin Sci Lond"},{"key":"11478_CR63","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/875403","volume":"2013","author":"P Seidel","year":"2013","unstructured":"Seidel P, Roth M (2013) Anti-inflammatory dimethylfumarate: a potential new therapy for asthma? Mediators Inflamm 2013:875403","journal-title":"Mediators Inflamm"},{"key":"11478_CR64","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/iid3.262","volume":"7","author":"AK Jaiswal","year":"2019","unstructured":"Jaiswal AK, Sandey M, Survawanshi A, Cattley RC, Mishra A (2019) Dimethyl fumarate abrogates dust mite-induced allergic asthma by altering dendritic cell function. Immun Inflamm Dis 7:201\u2013213","journal-title":"Immun Inflamm Dis"},{"key":"11478_CR65","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/toxres\/tfac020","volume":"11","author":"H Li","year":"2022","unstructured":"Li H, Li M, Dong C, Liu B (2022) Dimethyl fumarate ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NLRP3 inflammasome-mediated pyroptosis through enhancing Nrf2 singaling. Toxicol Res 11:437\u2013450","journal-title":"Toxicol Res"},{"key":"11478_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249658","volume":"21","author":"I Cattani-Cavalieri","year":"2020","unstructured":"Cattani-Cavalieri I, da Maia Valen\u00e7a H, Moraes JA, Brito-Gitirana L, Romana-Souza B, Schmidt M, Valen\u00e7a SS (2020) Dimethyl fumarate attenuates lung inflammation and oxidative stress induced by chronic exposure to diesel exhaust particles in mice. Int J Mol Sci 21:9658","journal-title":"Int J Mol Sci"},{"key":"11478_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106697","volume":"189","author":"F-L Shi","year":"2023","unstructured":"Shi F-L, Yuan L-S, Wong T-S, Li Q, Li Y-P, Xu R, You Y-P, Yuan T, Zhang H-R, Shi Z-J, Zha Q-B, Hu B, He X-H, Ouyang D-Y (2023) Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK2-MLKL axis. Pharmacol Res 189:106697","journal-title":"Pharmacol Res"},{"key":"11478_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18764-3","volume":"11","author":"D Olagnier","year":"2020","unstructured":"Olagnier D, Farahani E, Thyrsted J, Blay-Cadanet J, Herengt A, Idorn M, Hait A, Hernaez B, Knudsen A, Iversen MB, Schilling M, J\u00f8rgensen SE, Thomsen M, Reinert LS, Lappe M, Nielsen CG, M\u00f8ller C, van der Horst D, Peri S, Balachandran S, Huang J, Jakobsen M, Svenningsen EB, Poulsen TB, Bartsch L, Thielke AL, Luo Y, Alain T, Rehwinkel J, Alcam\u00ed A, Hiscott J, Mogensen TH, Paludan SR, Holm CK (2020) SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate. Nat Commun 11:4938","journal-title":"Nat Commun"},{"key":"11478_CR69","volume":"2022","author":"M Barzegar","year":"2022","unstructured":"Barzegar M, Houshi S, Sadeghi E, Hashemi MS, Pishgahi G, Bagherieh S, Afshari-Safavi A, Mirmosayyeb O, ShayganneJad V, Zabeti A (2022) Association of disease-modifying therapies with COVID-19 susceptibility and severity in patients with multiple sclerosis: a systematic review and network meta-analysis. Mult Scler Int 2022:9388813","journal-title":"Mult Scler Int"},{"key":"11478_CR70","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1212\/WNL.0000000000012753","volume":"97","author":"S Simpson-Yap","year":"2021","unstructured":"Simpson-Yap S, De Brouwer E, Kalincik T, Rijke N, Hillert JA, Walton C, Edan G, Moreau Y, Spelman T, Geys L, Parciak T, Gautrais C, Lazovski N, Pirmani A, Ardeshirdavanai A, Forsberg L, Glasser A, McBurney R, Schmidt H, Bergmann AB, Braune S, Stahmann A, Middleton R, Salter A, For RJ, van der Walt A, Butzkueven H, Alroughani R, Ozakbas S, Rojas JI, van der Mei I, Nag N, Ivanov R, Sciascia do Olival G, Dias AE, Magyari M, Brum D, Mendez MF, Alonso RN, Nicholas RS, Bauer J, Chertcoff AS, Zabalza A, Arrambide G, Fidao A, Comi G, Peeters L (2021) Associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis. Neurology 97:1870\u20131885","journal-title":"Neurology"},{"key":"11478_CR71","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000530764","volume":"32","author":"S Al-Shammri","year":"2023","unstructured":"Al-Shammri S, Chadha G, Chattopadhyay A, Doi S (2023) The impact of SARS-CoV-2 infection in unvaccinated multiple sclerosis patients on disease-modifying therapies. Med Princ Pract 32:143\u2013148","journal-title":"Med Princ Pract"},{"key":"11478_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103735","volume":"60","author":"TE Smith","year":"2022","unstructured":"Smith TE, Madhavan M, Gratch D, Patel A, Saha V, Sammarco C, Rimler Z, Zuniga G, Gragui D, Charvet L, Cutter G, Krupp L, Kister I, Zhovtis-Ryerson L (2022) Risk of COVID-19 infection and severe disease in MS patients on different disease-modifying therapies. Mult Scler Relat Disord 60:103735","journal-title":"Mult Scler Relat Disord"},{"key":"11478_CR73","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/med.21567","volume":"39","author":"NEB Saidu","year":"2019","unstructured":"Saidu NEB, Kavian N, Leroy K, Jacob C, Nicco C, Batteux F, Alexandre J (2019) Dimethyl fumarate, a two-edged drug: current status and future directions. Med Res Rev 39:1923\u20131952","journal-title":"Med Res Rev"},{"key":"11478_CR74","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jdermsci.2020.07.004","volume":"99","author":"T Takeda","year":"2020","unstructured":"Takeda T, Tsubaki M, Asano R, Itoh T, Imano M, Satou T, Nishida S (2020) Dimethyl fumarate suppresses metastasis and growth of melanoma cells by inhibiting the nuclear translocation of NF-\u03baB. J Dermatol Sci 99:168\u2013176","journal-title":"J Dermatol Sci"},{"key":"11478_CR75","doi-asserted-by":"publisher","first-page":"11888","DOI":"10.1158\/0008-5472.CAN-06-2397","volume":"66","author":"R Loewe","year":"2006","unstructured":"Loewe R, Valero T, Kremling S, Pratscher B, Kunstfeld R, Pehamberger H, Petzelbauer P (2006) Dimethylfumarate impairs melanoma growth and metastasis. Cancer Res 66:11888\u201311896","journal-title":"Cancer Res"},{"key":"11478_CR76","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/jid.2009.368","volume":"130","author":"T Valero","year":"2010","unstructured":"Valero T, Steele S, Neum\u00fcller K, Bracher A, Niederleithner H, Pehamberger H, Petzelbauer P, Loewe R (2010) Combination of dacarbazine and dimethylfumarate efficiently reduces melanoma lymph node metastasis. J Invest Dermatol 130:1087\u20131094","journal-title":"J Invest Dermatol"},{"key":"11478_CR77","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/carcin\/15.5.1049","volume":"15","author":"MA Pereira","year":"1994","unstructured":"Pereira MA, Barnes LH, Rassman VL, Kelloff GV, Steele VE (1994) Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis 15:1049\u20131054","journal-title":"Carcinogenesis"},{"key":"11478_CR78","first-page":"1199","volume":"15","author":"CV Rao","year":"1995","unstructured":"Rao CV, Rivenson A, Kelloff GJ, Reddy BS (1995) Chemoprevention of azomethane-induced colon cancer by ascorbylpalmitate, carbenoxolone, dimethylfumarate and p-methoxyphenol in male F344 rats. Anticancer Res 15:1199\u20131204","journal-title":"Anticancer Res"},{"key":"11478_CR79","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/sj.bjc.6602171","volume":"91","author":"A Begleiter","year":"2004","unstructured":"Begleiter A, Leith MK, Thliveris JA, Digby T (2004) Dietary induction of NQO1 increase the antitumour activity of mitomycin C in human colon tumours in vivo. Br J Cancer 91:1624\u20131631","journal-title":"Br J Cancer"},{"key":"11478_CR80","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00280-004-0961-4","volume":"56","author":"T Digby","year":"2005","unstructured":"Digby T, Leith MK, Thliveris JA, Begleiter A (2005) Effect of NQO1 induction on the antitumor activity of RH1 in human tumors in vitro and in vivo. Cancer Chemother Pharmacol 56:307\u2013316","journal-title":"Cancer Chemother Pharmacol"},{"key":"11478_CR81","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1074\/jbc.M115.679704","volume":"291","author":"I Kastrati","year":"2016","unstructured":"Kastrati I, Siklos MI, Calderon-Gierszal EL, El-Shennawy L, Georgieva G, Thayer EN, Thatcher GRJ, Frasor J (2016) Dimethyl fumarate inhibits the nuclear factor \u03baB pathway in breast cancer cells by covalent modification of p65 protein. J Biol Chem 291:3639\u20133647","journal-title":"J Biol Chem"},{"key":"11478_CR82","first-page":"1","volume":"10","author":"S Milad","year":"2022","unstructured":"Milad S, Ehsan J, Farzad MS, Mohsen R, Ahmad B, Shahram M, Niayesh M, Alireza K (2022) Effects of dimethyl fumarate on the Karnofsky performance status and serum S100\u03b2 level in newly glioblastoma patients: a randomized, phase-II, placebo, triple blinded, controlled trial: effect of DMF on the serum S100\u03b2 level and KPS score of GBM patients. Galen Med J 10:1\u201310","journal-title":"Galen Med J"},{"key":"11478_CR83","volume":"2","author":"D Shafer","year":"2020","unstructured":"Shafer D, Tombes MB, Shrader E, Ryan A, Bandyopadhyay D, Dent P, Malkin M (2020) Phase i trial of dimethyl fumarate, temozolomide, and radiation therapy in gliobastoma. Neurooncol Adv 2:vdz052","journal-title":"Neurooncol Adv"},{"key":"11478_CR84","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1182\/blood-2016-01-694117","volume":"128","author":"JP Nicolay","year":"2016","unstructured":"Nicolay JP, M\u00fcller-Decker K, Schroeder A, Brechmann M, M\u00f6bs M, G\u00e9raud C, Assaf C, Goerdt S, Krammer PH, G\u00fclow K (2016) Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-\u03baB. Blood 128:805\u2013815","journal-title":"Blood"},{"key":"11478_CR85","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1182\/blood.2022018669","volume":"142","author":"JP Nicolay","year":"2023","unstructured":"Nicolay JP, Melchers S, Albrecht JD, Assaf C, Dippel E, Stadler R, Wehkamp U, Wobser M, Zhao J, Burghaus I, Schneider S, G\u00fclow K, Goerdt S, Sch\u00fcrch CM, Utikal JS, Krammer PH (2023) Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study. Blood 142:794\u2013805","journal-title":"Blood"},{"key":"11478_CR86","doi-asserted-by":"publisher","first-page":"8192","DOI":"10.3390\/ijms23158192","volume":"23","author":"T Rupp","year":"2022","unstructured":"Rupp T, Debasly S, Genest L, Froget G, Castagn\u00e9 V (2022) Therapeutic potential of fingolimod and dimethyl fumarate in non-small cell lung cancer preclinical models. Int J Mol Sci 23:8192","journal-title":"Int J Mol Sci"},{"key":"11478_CR87","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.bbrc.2019.11.100","volume":"522","author":"DK Dwivedi","year":"2020","unstructured":"Dwivedi DK, Jena GB (2020) Diethylnitrosamine and thioacetamide-induced hepatic damage and early carcinogenesis in rats: role of Nrf2 activator dimethyl fumarate and NLRP3 inhibitor glibenclamide. Biochem Biophys Res Commun 522:381\u2013387","journal-title":"Biochem Biophys Res Commun"},{"key":"11478_CR88","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jsbmb.2018.11.017","volume":"188","author":"M Nachliely","year":"2019","unstructured":"Nachliely M, Trachtenberg A, Khalfin B, Nalbandyan K, Cohen-Lahav M, Yasuda K, Sakaki T, Kutner A, Danilenko M (2019) Dimethyl fumarate and vitamin D derivative cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model. J Steroid Biochem Mol Biol 188:8\u201316","journal-title":"J Steroid Biochem Mol Biol"},{"key":"11478_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032777","volume":"24","author":"R Basilotta","year":"2023","unstructured":"Basilotta R, Lanza M, Filippone A, Casili G, Mannino D, De Gaetano F, Chisari G, Colarossi L, Motta G, Campolo M, Cuzzocrea S, Paternini I, Esposito E (2023) Therapeutic potential of dimethyl fumarate in counteract oral squamous cell carcinoma progression by modulating apoptosis, oxidative stress and epithelial-mesenchymal transition. Int J Mol Sci 24:2777","journal-title":"Int J Mol Sci"},{"key":"11478_CR90","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jdcr.2022.11.003","volume":"31","author":"A Al-Omair","year":"2023","unstructured":"Al-Omair A, Alharbi M, Almesfer A (2023) Dimethyl fumarate for treating Papillon-Lef\u00e8vre syndrome. JAAD Case Rep 31:19\u201322","journal-title":"JAAD Case Rep"},{"key":"11478_CR91","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1111\/j.1468-3083.2011.04303.x","volume":"26","author":"A Klein","year":"2012","unstructured":"Klein A, Coras B, Landthaler M, Babilas P (2012) Off-label use of fumarate therapy for granulomatous and inflammatory skin diseases other than psoriasis vulgaris: a retrospective study. J Eur Acad Dermatol Venereol 26:1400\u20131406","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"11478_CR92","volume":"15","author":"A Dodej\u00e1","year":"2023","unstructured":"Dodej\u00e1 A, Meshram K, Pande S, Oke M, Borkar M (2023) Oral tofacitinib therapy for the effective management of Netherton syndrome. Cureus 15:e39349","journal-title":"Cureus"},{"key":"11478_CR93","doi-asserted-by":"publisher","DOI":"10.1111\/pai.70039","volume":"36","author":"BE Wilson","year":"2025","unstructured":"Wilson BE, Grebe TA, Prakash S, Bauer CS (2025) Systemic JAK inhibitors for treatment of cutaneous manifestations in a patient with SPINK5 variants: a case report and review of the literature. Pediatr Allergy Immunol 36:e70039","journal-title":"Pediatr Allergy Immunol"},{"key":"11478_CR94","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.042648","volume":"13","author":"S Muzumdar","year":"2020","unstructured":"Muzumdar S, Koch M, Hiebert H, Bapst A, Gravina A, Bloch W, Beer H-D, Werner S, Sch\u00e3fer M (2020) Genetic activation of Nrf2 reduces cutaneous symptoms in a murine model of Netherton syndrome. Dis Model Mech 13:dmm042648","journal-title":"Dis Model Mech"},{"key":"11478_CR95","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1084\/jem.20172060","volume":"215","author":"A Kanneganti","year":"2018","unstructured":"Kanneganti A, Malireddi RKS, Saavedra PHV, Vande Walle L, Van Gorp H, Kambara H, Tillman H, Vogel P, Luo HR, Xavier RJ, Chi H, Lamkanfi M (2018) GSDMD is critical for autoinflammatory pathology in a mouse model of familial mediterranean fever. J Exp Med 215:1519\u20131529","journal-title":"J Exp Med"},{"key":"11478_CR96","volume":"1","author":"EE Longbrake","year":"2015","unstructured":"Longbrake EE, Naismith RT, Parks BJ, Wu GF, Cross AH (2015) Dimethyl fumarate-associated lymphopenia: risk factors and clinical significance. Mult Scler J Exp Transl Clin 1:2055217315596994","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"11478_CR97","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/1352458520949158","volume":"28","author":"AL Jordan","year":"2022","unstructured":"Jordan AL, Yang J, Fisher C, Racke M, Mao-Draayer Y (2022) Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients. Mult Scler 28:7\u201315","journal-title":"Mult Scler"},{"key":"11478_CR98","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1365-4632.2011.04916.x","volume":"51","author":"AM D\u2019 Erme","year":"2012","unstructured":"D\u2019 Erme AM, Bassi A, Lotti T, Gola M (2012) Dimethyl fumarate contact dermatitis of the foot: and increasingly widespread disease. Int J Dermatol 51:42\u201345","journal-title":"Int J Dermatol"},{"key":"11478_CR99","doi-asserted-by":"publisher","first-page":"P1562","DOI":"10.1016\/j.jaip.2022.12.048","volume":"11","author":"I Baglivo","year":"2023","unstructured":"Baglivo I, Colantuono S, Caruso C, De Fino C, Gasbarrini A, Capone M, D\u2019 Amore A, Peris K, Romano A, Parronchi P (2023) Delayed hypersensitivity to dimethyl fumarate: report of 1 case and literature review. J Allergy Clin Immunol 11:P1562-1563","journal-title":"J Allergy Clin Immunol"},{"key":"11478_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2015.11.003","author":"G Miglio","year":"2016","unstructured":"Miglio G, Sabatino AD, Veglia E, Giraudo MT, Beccuti M, Cordero F (2016) A computational analysis of S-(2-succino)cysteine sites in proteins. Biochimica et Biophysica Acta (BBA). https:\/\/doi.org\/10.1016\/j.bbapap.2015.11.003","journal-title":"Biochimica et Biophysica Acta (BBA)"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11478-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11478-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11478-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T13:03:28Z","timestamp":1770037408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11478-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11478"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11478-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Non relevant. The study does not involve humans or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"344"}}